Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Alamir1111 on Feb 12, 2024 3:11pm

Pfizer

Yesterday at Superbowl pfizer had 2 ads going .It costs about 7 mil for one 30 second ad.
Comment by O12009 on Feb 12, 2024 7:10pm
They were talking about game changing innovations coming for the treatment of cancer.I feel they must be in talks with Theralase Technologies, looking to step up there play in the cancer market. Smart move by them.
Comment by Longholder99 on Feb 12, 2024 7:33pm
I don't doubt that at all.  Having a head start on multi indication treatment options using an FDA BTD approved drug, would leap frog any big Pharm over their xompetitors' Frankenstein class immuno manipulation drugs of the 90s.  What makes you think it though? 
Comment by O12009 on Feb 12, 2024 7:58pm
Back about six months ago ,I read about which big pharmaceutical companies was leading in the oncology field and who was looking to boost their share of the market. Pfizer was the one who appears to be wanting to buy promising new technologies to boost there drug portfolio. They have a ton of money from sales in Covid vaccine market and we would be a great buy for them at this time.
Comment by 99942Apophis on Feb 12, 2024 8:34pm
Longholder99 wrote  I don't doubt that at all.  Having a head start on multi indication treatment options using an FDA BTD approved drug, would leap frog any big Pharm over their xompetitors' Frankenstein class immuno manipulation drugs of the 90s.  What makes you think it though?  Love your picturesque description Longholder99!  The conversation here is one that ...more  
Comment by O12009 on Feb 12, 2024 9:12pm
If and when we get BTD I believe we will have a deal that may fund a GBM trial or lung trial or we could go way out and it could be a trial for Covid cure. This should give us a better hint of who the suitor is. If AA happens we could be bought out before years end, and it could be a bidding war.
Comment by DeathXray33 on Feb 13, 2024 12:14pm
@ > 1.273 mil now...
Comment by Alamir1111 on Feb 12, 2024 9:12pm
012009 good one.After Btd  Aa things could get intersting 
Comment by Alamir1111 on Feb 12, 2024 9:41pm
Seems to me pfizer is piggybacking on bcg.https://classic.clinicaltrials.gov/ct2/show/NCT04165317
Comment by Gooseybear on Feb 13, 2024 10:51am
  Pfizer is in bed with the FDA.. Lucira Health was a small company with a great product awaiting FDA breakthrough designation. They subsequently ran out of money due to delays and Pfizer was able to scoop them up at a BK auction. The  week after filing BK, the FDA approved the product. I sincerely hope this is not what the FDA is doing to TLTF.
Comment by blackjack0 on Feb 13, 2024 11:23am
Covid Test Maker Lucira Goes Bankrupt as Demand for Kits Wanes Publicly traded company makes at-home test kits for Covid-19 Lucira has assets of $146 million and debts of $85 million                                                       not a valid ...more  
Comment by 99942Apophis on Feb 13, 2024 11:27am
Gooseybear their product was authorized here in Canada however it took 30 minutes to get results which would only be good for home use, in comparison to other testing kits that could do it faster. In a sense they would be comparable to current NMIBC treatments and when Theralase will be available to that market how many will accuse the FDA of being in bed with the company? You know once Theralase ...more  
Comment by Gooseybear on Feb 13, 2024 1:47pm
Why do you think Pfizer decided to take on a small company with an inferior product?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250